Cancer medicines

Cetuximab

Cetuximab

An EGFR-targeting antibody for selected colorectal and head and neck cancers.

Sources checked · Introductory guide

On this page

How it works

It binds EGFR to block cell growth signaling.[3]

Where it is used

Used in selected metastatic colorectal and head and neck squamous cancers. Colorectal use requires review of RAS and other molecular results and the combination regimen.[1]

Key safety points

Monitor infusion reactions, skin symptoms and electrolyte loss. Report breathlessness, swelling or faintness during infusion immediately.[2]

Questions for your care team

  • How do my molecular results guide treatment, skin care and magnesium monitoring?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Cetuximab (opens in a new tab)
  2. MedlinePlus · Cetuximab (opens in a new tab)
  3. NCI Drug Dictionary · Cetuximab (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Cetuximab | Cancer Encyclopedia | My Chemo Diary